Krystal Biotech

US · KRYS #1515 by market cap Listed 2017

324.57 -2.24 -0.69%

Live - 5344 symbols - heartbeat 303s ago · 2026-10-08 05:56

Pre-market 324.57 0.00%

After-hours 324.57 0.00%

Market cap: 9.61B
P/E (TTM): 40.67
P/B: 7.07
EPS: 6.84
Div yield: 0.00%
52W pos: 71%

Reader sentiment Are you bullish or bearish on KRYS?

Anonymous reader poll. Unscientific, not investment advice.

About Krystal Biotech

Krystal Biotech, Inc. operates as a biotechnology company, which engages in discovery, development, manufacturing, and commercialization of pharmaceutical products. It offers the product, VYJUVEK. The company was founded by Krish S. Krishnan and Suma M. Krishnan on April 15, 2016 and is headquartered in Pittsburgh, PA.

Founded: 2016
CEO: Mr. Krish S. Krishnan
Employees: 295
Headquarters: Pittsburgh, Pennsylvania, United States of America
Fiscal year end: 12-31
Website: krystalbio.com

Company profile

Exchange: US
Symbol: KRYS
Market-cap rank: #1515
Listing date: 2017-09-20
Market cap: 9.61B
Float cap: 7.67B
Shares out: 29.60M
Float shares: 23.62M

Sectors & themes

Biotechnology Fractional Shares JP

Browse all sectors & themes

Quote time 2026-10-08 05:56:28 · For reference only, not investment advice and not tailored to your situation.